92 related articles for article (PubMed ID: 23657987)
1. siRNA associated with immunonanoparticles directed against cd99 antigen improves gene expression inhibition in vivo in Ewing's sarcoma.
Ramon AL; Bertrand JR; de Martimprey H; Bernard G; Ponchel G; Malvy C; Vauthier C
J Mol Recognit; 2013 Jul; 26(7):318-29. PubMed ID: 23657987
[TBL] [Abstract][Full Text] [Related]
2. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
3. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
4. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapies in Ewing's sarcoma.
Scotlandi K
Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
[TBL] [Abstract][Full Text] [Related]
6. Murine model for skeletal metastases of Ewing's sarcoma.
Scotlandi K; Benini S; Manara MC; Serra M; Nanni P; Lollini PL; Nicoletti G; Landuzzi L; Chano T; Picci P; Baldini N
J Orthop Res; 2000 Nov; 18(6):959-66. PubMed ID: 11192257
[TBL] [Abstract][Full Text] [Related]
7. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
[TBL] [Abstract][Full Text] [Related]
8. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
[TBL] [Abstract][Full Text] [Related]
9. Extraskeletal Ewing's sarcoma of the hard palate.
Kang MS; Yoon HK; Choi JB; Eum JW
J Korean Med Sci; 2005 Aug; 20(4):687-90. PubMed ID: 16100468
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
[TBL] [Abstract][Full Text] [Related]
11. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
[TBL] [Abstract][Full Text] [Related]
13. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
[TBL] [Abstract][Full Text] [Related]
14. MIC2 detection in tumors of bone and adjacent soft tissues.
Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
[TBL] [Abstract][Full Text] [Related]
15. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
Fellinger EJ; Garin-Chesa P; Triche TJ; Huvos AG; Rettig WJ
Am J Pathol; 1991 Aug; 139(2):317-25. PubMed ID: 1867320
[TBL] [Abstract][Full Text] [Related]
17. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
Hu-Lieskovan S; Heidel JD; Bartlett DW; Davis ME; Triche TJ
Cancer Res; 2005 Oct; 65(19):8984-92. PubMed ID: 16204072
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal rearrangement t(11;22) in extraskeletal Ewing's sarcoma and primitive neuroectodermal tumour analysed by fluorescence in situ hybridization using paraffin-embedded tissue.
Nagao K; Ito H; Yoshida H; Minamizaki T; Furuse K; Yoshikawa T; Ushigome S
J Pathol; 1997 Jan; 181(1):62-6. PubMed ID: 9072004
[TBL] [Abstract][Full Text] [Related]
19. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
20. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
